Quick Answer
BIO-PATH HOLDINGS, INC. reported R&D Expense of $7.29 million for fiscal year 2024.
BIO-PATH HOLDINGS, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $7.29M | -37.2% |
| 2023 | $11.61M | +26.7% |
| 2022 | $9.16M | +55.1% |
| 2021 | $5.91M | -10.2% |
| 2020 | $6.58M | +43.5% |
| 2019 | $4.58M | -0.4% |
| 2018 | $4.60M | -16.0% |
| 2017 | $5.48M | +0.1% |
| 2016 | $5.47M | +81.3% |
| 2015 | $3.02M | +85.3% |
| 2014 | $1.63M | +7.3% |
| 2013 | $1.52M | +34.1% |
| 2012 | $1.13M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $275.0K | -79.1% | -93.2% |
| June 30, 2025 | $4.05M | +116.1% | +104.8% |
| March 31, 2025 | $1.98M | -13.6% | +50.1% |
| September 30, 2024 | $1.32M | -42.5% | -29.7% |
| June 30, 2024 | $1.87M | -38.6% | -18.1% |
| March 31, 2024 | $2.29M | -42.6% | -0.2% |
| September 30, 2023 | $2.29M | -2.6% | -24.9% |
| June 30, 2023 | $3.05M | +64.8% | -23.5% |
- BIO-PATH HOLDINGS, INC. showed a decrease of -37.2% in R&D Expense compared to the prior fiscal year.
- Over the 2012–2024 period, BIO-PATH HOLDINGS, INC.’s r&d expense has grown by 544.0% (from $1.13 million to $7.29 million).
- The most recent figure is from BIO-PATH HOLDINGS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: